Antibacterial polymers have potential as pharmaceuticals and as coatings for implantation devices. The design of these materials will be optimized when we have a complete understanding of the structural features that impart activity toward target organisms and those that are benign with respect to the mammalian host. In this work, four series of polymers in which cationic and hydrophobic groups were distributed along the backbone were tested against six different bacterial species (both Gram positive and Gram negative) and for host cytotoxicities (red blood cell lysis). The most effective of the polymers studied are regularly spaced, featuring a 6-8 carbon stretch along the backbone between side chains that present positively charged groups. They cause potassium efflux, disorder the bacterial cytoplasmic membrane, and disrupt the membrane potential. These polymers, available from alternating ring opening metathesis polymerization (AROMP), offer proof of principle for the importance of regular spacing in antibacterial polymers and for the synthesis of additional functional materials based on regularly spaced scaffolds.In the more than 80 years since Fleming discovered penicillin, humans have expended a great deal of effort in the search for, optimization of, and testing of new antibiotics. During the same period, new pathogens have appeared and antibiotic-resistant strains have evolved. The war against the microbes is far from over (1).Of particular concern in the western world is the incidence of hospital-acquired infections and the drug resistance of many of the causative phenotypes (2,3). The appearance of methicillin-resistant Staphylococcus aureus (4) and resistant strains of pneumonia and tuberculosis (5,6) as community-acquired infections have served to focus public attention on this growing health problem, leading The Infectious Diseases Society of America to call for renewed efforts to develop antimicrobial therapies (7).One attractive avenue for new antibiotic development is the exploitation or development of "host-defense" antimicrobial peptides (AMPs). Eukaryotes produce these small peptides (about 12 to 80 amino acid residues) as part of their innate immune response against pathogen infection (8-10). Some AMPs are preorganized so that they are amphipathic; i.e. cationic residues are segregated from hydrophobic residues onto opposing faces of the peptide (11). Others, it appears, are induced to adopt an amphipathic topology by contact with cell membranes (or, in laboratory experiments, with micellar surfaces). The inherent or induced amphipathic conformation of an AMP facilitates binding to and insertion into lipid bilayers. Subsequent disruption of the cytoplasmic membrane (8) can lead to bacterial death. Alternatively, some antimicrobial peptides are thought to cause cell death by additional mechanisms (11) including membrane depolarization, binding to cytoplasmic components (12,13), and inhibition of cell wall synthesis (14). Regardless of the killing mechanism, the ability to interact with...